Plasma asymmetrical-dimethyl-arginine (ADMA) regulates nitric oxide bioavailability and vascular superoxide production in human vessels
Principais autores: | Antoniades, C, Shirodaria, C, Leeson, P, Tousoulis, D, Pillai, R, Ratnatunga, C, Vasiliadou, C, Antonopoulos, A, Stefanadis, C, Channon, K |
---|---|
Formato: | Journal article |
Publicado em: |
2007
|
Registros relacionados
-
Plasma asymmetrical-dimethyl-arginine (ADMA) as a regulator of vascular redox and nitric oxide bioavailability in human vessels
por: Antoniades, C, et al.
Publicado em: (2007) -
Plasma asymmetrical-dimethyl-arginine affects eNOS vascular superoxide radical production and nitric oxide bioavailability in human arteries and veins
por: Antoniades, C, et al.
Publicado em: (2008) -
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
por: Antoniades, C, et al.
Publicado em: (2009) -
Genetic Polymorphism On Methyl-Tetrahydrofolate-Reductase Affects Vascular Superoxide Generation and Nitric Oxide Bioavailability By Regulating eNOS Coupling in Human Arteries and Veins
por: Antoniades, C, et al.
Publicado em: (2009) -
Genetic variability of MTHFR affects vascular redox and nitric oxide bioavailability in human vessels, by modifying eNOS coupling
por: Antoniades, C, et al.
Publicado em: (2008)